Rethinking healthcare quality and safety in the age of COVID

Rethinking healthcare quality and safety in the age of COVID

Early in the pandemic, CMS suspended quality reporting during the first two quarters of 2020. That will create a gap in data that would normally be available to assess trends in the industry and to spur process improvements. CMS “is

Read More Rethinking healthcare quality and safety in the age of COVID

WATCH: Top experts answer questions about vaccine safety, effectiveness and availability

WATCH: Top experts answer questions about vaccine safety, effectiveness and availability

Two top Advocate Aurora Health doctors on Wednesday addressed viewer questions about vaccines, COVID-19, masks and when life might get back to normal during a discussion on Facebook Live. Executive Medical Director of Infectious Disease and Prevention Dr. Robert Citronberg

Read More WATCH: Top experts answer questions about vaccine safety, effectiveness and availability

FDA review supports safety, efficacy of J&J coronavirus vaccine

FDA appoints first medical device cybersecurity chief

Scientists at the Food and Drug Administration found Johnson & Johnson’s coronavirus vaccine to be safe and effective in preventing COVID-19, confirming clinical trial results announced by the drugmaker last month and likely clearing the way for an emergency authorization in

Read More FDA review supports safety, efficacy of J&J coronavirus vaccine

The year to come in life sciences safety and regulatory practices

How 2020 has shaped the future of healthcare

The fruitful endeavors of the life sciences industry are impossible to miss. The year 2021 begins with two Covid-19 vaccines developed, tested and approved for use in just under a year along with multiple treatments, diagnostics and other medical technology.

Read More The year to come in life sciences safety and regulatory practices

Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults

Prediabetes, Diabetes, and the Risk of All-Cause and Cause-Specific Mortality in a Japanese Working Population: Japan Epidemiology Collaboration on Occupational Health Study

Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults Elisabetta Patorno, Ajinkya Pawar, Lily G. Bessette, Dae H. Kim, Chintan Dave, Robert J. Glynn, Medha N. Munshi, Sebastian Schneeweiss, Deborah J.

Read More Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults

The SEE Study: Safety, Efficacy, and Equity of Implementing Autonomous Artificial Intelligence for Diagnosing Diabetic Retinopathy in Youth

Prediabetes, Diabetes, and the Risk of All-Cause and Cause-Specific Mortality in a Japanese Working Population: Japan Epidemiology Collaboration on Occupational Health Study

The SEE Study: Safety, Efficacy, and Equity of Implementing Autonomous Artificial Intelligence for Diagnosing Diabetic Retinopathy in Youth Risa M. Wolf, T.Y. Alvin Liu, Chrystal Thomas, Laura Prichett, Ingrid Zimmer‐Galler, Kerry Smith, Michael D. Abramoff, Roomasa Channa Diabetes Care Mar

Read More The SEE Study: Safety, Efficacy, and Equity of Implementing Autonomous Artificial Intelligence for Diagnosing Diabetic Retinopathy in Youth

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)

Prediabetes, Diabetes, and the Risk of All-Cause and Cause-Specific Mortality in a Japanese Working Population: Japan Epidemiology Collaboration on Occupational Health Study

AbstractOBJECTIVE To compare efficacy and safety of dulaglutide at doses of 3.0 and 4.5 mg versus 1.5 mg in patients with type 2 diabetes inadequately controlled with metformin.RESEARCH DESIGN AND METHODS Patients were randomly assigned to once-weekly dulaglutide 1.5 mg,

Read More Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)

Safety and Efficacy of Dietary Supplements for Diabetes

Tedious, Tiresome, and Dull: An Unrecognized Problem That We Can Solve

Results from various surveys show that 30–70% of adult people with diabetes in the United States use alternative medicine, with one-third using it specifically to improve diabetes-related symptoms (1). Individuals with diabetes may be inclined to use these products for

Read More Safety and Efficacy of Dietary Supplements for Diabetes

As Millions Get Shots, F.D.A. Struggles to Get Safety Monitoring System Running

As Millions Get Shots, F.D.A. Struggles to Get Safety Monitoring System Running

“It’s great for routine stuff, but when it comes to safety surveillance, it’s all about size,” said Dr. Daniel Salmon, director of the Institute for Vaccine Safety at Johns Hopkins University, and a former federal vaccine official. “The bigger it

Read More As Millions Get Shots, F.D.A. Struggles to Get Safety Monitoring System Running

Schools Walk the Tightrope Between Ideal Safety and the Reality of Covid

Schools Walk the Tightrope Between Ideal Safety and the Reality of Covid

Laura Ungar and Samantha Young California mom Megan Bacigalupi has had enough. She wants her kindergartner and second grader back in their Oakland classrooms. This story also ran on USA Today. It can be republished for free. But the coronavirus

Read More Schools Walk the Tightrope Between Ideal Safety and the Reality of Covid